Research Review - Group B Meningococcal Disease in New Zealand: Epidemiology and Prevention Tuesday, 19 March 2019

A research review educational series, this publication reviews risk factors, incidence and burden associated with meningococcal disease, focusing on the New Zealand setting. Vaccines available for meningococcal disease in New Zealand are discussed, including an in-depth review of 4CMenB (BEXSERO®), the only vaccine available in this country for group B disease.

Paediatrician Dr Sharon Wong, and GP Dr Stewart Reid provide independent commentary on this review of risk factors, incidence and burden associated with meningococcal disease, focusing on the New Zealand setting.

Read the full report here.